Immunotherapy is a type of cancer treatment that boosts the body’s natural defences to fight the cancer.
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.
Around 35,600 people die from lung cancer each year in the UK, making it the most common cause of cancer death in the UK.
Researchers at the University of Southampton and La Jolla Institute for Allergy and Immunology, California, found lung cancer patients with large amounts of a particular type of immune T-cell, called tissue-resident memory T-cells, in their tumour were 34 per cent less likely to die.
The study also found that it was not just the numbers of cells that increased survival, but the cells’ behaviour played a key role.
Femi Ashekun/ Handheld walkie-talkies used by Hizbollah were detonated across Lebanon today, the militant group…
… Identifies Challenges and Solutions for Humanitarian Interventions In an exclusive interview, Mohamed Malick Fall,…
Segun Atanda/ In a nationwide crackdown on crime, the Nigeria Police Force has arrested 2,740…
Segun Atanda/ Former Lagos State Commissioner of Police, Adegoke Fayoade, officially handed over to his…
By Ifeanyi Igwebike Mbanefo/ On 17 September 2016, I was scrolling through Cable online news…
Matilda Omonaiye/ The FBI is investigating another apparent assassination attempt on former President Donald Trump…